Cargando…

Comparison of the rapidity of SARS-CoV-2 immune responses between primary and booster vaccination for COVID-19

BACKGROUND/AIMS: The rapidity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific memory B or T cell response in vaccinated individuals is important for our understanding of immunopathogenesis of coronavirus disease 2019 (COVID-19). We therefore compared the timing of adequate i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ji Yeun, Kwon, Ji-Soo, Cha, Hye Hee, Lim, So Yun, Bae, Seongman, Kim, Sung-Han
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association of Internal Medicine 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666257/ https://www.ncbi.nlm.nih.gov/pubmed/36217813 http://dx.doi.org/10.3904/kjim.2022.173

Ejemplares similares

Comparison of antibody responses after the 1st and 2nd doses of COVID-19 vaccine with those of patients with mild or severe COVID-19
por: Cha, Hye Hee, et al.
Publicado: (2022)

288. Analysis of serum antibody response as correlates of protection against SARS-CoV-2 infection and the effects of BA.4/5 bivalent booster vaccination
por: Yun Lim, So, et al.
Publicado: (2023)

Contamination of personal protective equipment by SARS-CoV-2 during routine care of patients with mild COVID-19
por: Jung, Jiwon, et al.
Publicado: (2020)

Immune responses and reactogenicity after ChAdOx1 in individuals with past SARS-CoV-2 infection and those without
por: Lim, So Yun, et al.
Publicado: (2022)

Transmission Characteristics of SARS-CoV-2 That Hinder Effective Control
por: Bae, Seongman, et al.
Publicado: (2021)

Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals
por: Jung, Jiwon, et al.
Publicado: (2022)

Comparison of Waning Immunity Between Booster Vaccination and 2-Dose Vaccination With BNT162b2
por: Jung, Jiwon, et al.
Publicado: (2022)

SARS-CoV-2-Specific Antibody and T Cell Response Kinetics According to Symptom Severity
por: Kim, Ji Yeun, et al.
Publicado: (2021)

Diagnostic usefulness of subgenomic RNA detection of viable SARS-CoV-2 in patients with COVID-19
por: Kim, Ji Yeun, et al.
Publicado: (2022)

Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infection
por: Kang, Sung Woon, et al.
Publicado: (2022)

1467. Breakthrough Omicron Infections in Booster Vaccinated Healthcare Workers
por: Lee, Jeongjae, et al.
Publicado: (2022)

Comparison of Antibody and T Cell Responses Induced by Single Doses of ChAdOx1 nCoV-19 and BNT162b2 Vaccines
por: Kim, Ji Yeun, et al.
Publicado: (2021)

Daily, self-test rapid antigen test to assess SARS-CoV-2 viability in de-isolation of patients with COVID-19
por: Bae, Seongman, et al.
Publicado: (2022)

Correlation between Reactogenicity and Immunogenicity after the ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccination
por: Lim, So Yun, et al.
Publicado: (2021)

Corrigendum to “Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infection” [J Infect 85 (2022) e69–e71]
por: Kang, Sung Woon, et al.
Publicado: (2023)

No correlation of neutralizing antibody titers against the Omicron variant after a booster dose of COVID-19 vaccines with subsequent breakthrough Omicron infections among healthcare workers
por: Lee, Jeongjae, et al.
Publicado: (2022)

Comparison of the clinical and virological characteristics of SARS-CoV-2 Omicron BA.1/BA.2 and omicron BA.5 variants: A prospective cohort study
por: Kang, Sung-Woon, et al.
Publicado: (2023)

Evaluation of the Efficacy of COVID-19 Booster Vaccinations in Healthcare Personnel
por: Kim, Chung-Jong, et al.
Publicado: (2022)

Rapid Evaluation of Vaccine Booster Effectiveness against SARS-CoV-2 Variants
por: Cheng, Hoi Lok, et al.
Publicado: (2022)

Adverse Reactions of the Second Dose of the BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers in Korea
por: Lee, Yun Woo, et al.
Publicado: (2021)

Rapid COVID-19 Molecular Diagnostic System Using Virus Enrichment Platform
por: Jang, Yoon Ok, et al.
Publicado: (2021)

464. Whole Genome Sequencing and Mutation Analysis of SARS-CoV-2 in the Immunocompromised Patients with Persistent SARS-CoV-2 Shedding
por: Chang, Eui Jin, et al.
Publicado: (2023)

Breakthrough infections and waning immune responses with ChAdOx1 nCoV‐19 or mRNA vaccine in healthcare workers
por: Lim, So Yun, et al.
Publicado: (2022)

Dynamics of Viral Shedding and Symptoms in Patients with Asymptomatic or Mild COVID-19
por: Bae, Seongman, et al.
Publicado: (2021)

Adverse Reactions Following the First Dose of ChAdOx1 nCoV-19 Vaccine and BNT162b2 Vaccine for Healthcare Workers in South Korea
por: Bae, Seongman, et al.
Publicado: (2021)

Risk of Absence of Measles Antibody in Healthcare Personnel and Efficacy of Booster Vaccination
por: Kim, Chung-Jong, et al.
Publicado: (2021)

Comparison of the causes of death associated with delta and Omicron SARS-CoV-2 variants infection
por: Kim, A Reum, et al.
Publicado: (2023)

SARS-CoV2 vaccine boosters for India
por: Kang, Gagandeep
Publicado: (2022)

Factors of Severity in Patients with COVID-19: Cytokine/Chemokine Concentrations, Viral Load, and Antibody Responses
por: Kwon, Ji-Soo, et al.
Publicado: (2020)

Comparison of culture-competent virus shedding duration of SARS-CoV-2 Omicron variant in regard to vaccination status: A prospective cohort study
por: Kang, Sung-Woon, et al.
Publicado: (2023)

Nosocomial Outbreak of COVID-19 in a Hematologic Ward
por: Jung, Jiwon, et al.
Publicado: (2021)

Recent Hydroxychloroquine Use Is Not Significantly Associated with Positive PCR Results for SARS-CoV-2: A Nationwide Observational Study in South Korea
por: Bae, Seongman, et al.
Publicado: (2021)

Booster Vaccination Strategies for “Living With COVID-19”
por: Kim, Jung Eun, et al.
Publicado: (2022)

Antibody response to SARS-CoV-2 booster vaccines
por: Loving, Hanna S., et al.
Publicado: (2022)

Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection
por: Hyun, Hakjun, et al.
Publicado: (2023)

Heterologous ChAdOx1 and Bnt162b2 vaccination induces strong neutralizing antibody responses against SARS-CoV-2 including delta variant with tolerable reactogenicity
por: Bae, Seongman, et al.
Publicado: (2022)

Acute T cell-mediated rejection after administration of the BNT162b2 mRNA COVID-19 vaccine in a kidney transplant recipient: a case report
por: Jang, Hye-Won, et al.
Publicado: (2021)

Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report
por: Atmar, Robert L., et al.
Publicado: (2021)

SARS-CoV-2 vaccine boosters: The time to act is now
por: Petersen, Maya, et al.
Publicado: (2021)

The societal value of SARS-CoV-2 booster vaccination in Indonesia
por: Johnson, Rob, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a13de16qtegcp01i6j8l8lphdh